Abstracts

TRENDS AND CHARACTERISTICS OF HIV-1 DRUG RESISTANCE IN THE UNITED STATES (2012-2018)

The prevalence of transmitted and acquired HIV-1 drug resistance impacts effectiveness of antiretroviral therapy in both treatment-naïve and treatment-experienced people living with HIV. This analysis utilized data from a large, representative commercial patient testing database to assess trends in HIV-1 resistance prevalence in the modern treatment era. Samples from HIV-1-infected individuals in the United States…

PRETREATMENT HIV DRUG RESISTANCE AND 48-WEEK VIROLOGIC OUTCOMES IN THE ADVANCE TRIAL

Increasing prevalence of pretreatment HIV drug resistance (PDR) has motivated guideline changes to avoid non-nucleoside reverse transcriptase (NNRTI)-based first-line antiretroviral therapy (ART) regimens. Empiric data on the performance of ART regimens in the face of PDR are lacking in sub-Saharan Africa. The ADVANCE study is a randomized controlled trial in South Africa that compares efavirenz…

TENOFOVIR DIPHOSPHATE IN DRIED BLOOD SPOTS PREDICTS VIROLOGIC FAILURE AND RESISTANCE

Tenofovir diphosphate (TFV-DP) in dried blood spots (DBS) is a measure of cumulative adherence and exposure to TFV-based antiretroviral therapy (ART). This adherence biomarker has been associated with viral suppression and found to predict future viremia in persons living with HIV (PLWH) receiving tenofovir disoproxil-fumarate (TDF)-based ART. However, little is known about its utility in…

COUNTRY-LEVEL DRIVERS OF NNRTI RESISTANCE IN SOUTHERN AFRICA

The rise in the prevalence of drug resistance to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) in HIV-infected individuals initiating antiretroviral therapy (ART) is a major problem in countries of southern Africa. Understanding the dynamics and drivers of NNRTI resistance at the country level is of critical importance for planning future ART programs. We first collected survey data…

PRETREATMENT AND ACQUIRED ANTIRETROVIRAL DRUG RESISTANCE IN 4 AFRICAN COUNTRIES

Standardized HIV management protocols that emphasize adherence counseling and forego genotypic testing for HIV drug resistance (HIVDR) have facilitated expanded access to antiretroviral therapy (ART) in resource-limited settings. However, emerging HIVDR could jeopardize the success of such approaches. We characterized HIVDR among ART-naïve and experienced participants in the ongoing African Cohort Study (AFRICOS). From January…

TRANSMITTED DRUG RESISTANCE IN PEOPLE LIVING WITH DIAGNOSED HIV IN CALIFORNIA

Increased antiretroviral use for treatment and prevention raises concern that rates of transmitted drug resistance may increase. We analyzed a population-based dataset of HIV-1 pol sequences to estimate the prevalence of transmitted drug resistance-associated mutations (DRAMs) in people living with HIV in California from 2008-2018 and evaluated the transmission potential of identified mutations. HIV-1 pol…